Tags: Drug.
Imagabalin (INN USAN; PD-332334) is a drug which acts as a ligand for the α2δ subunit of the voltage-dependent calcium channel with some selectivity for the α2δ1 subunit over α2δ2. Under development by Pfizer as a pharmaceutical medication it has demonstrated preclinical efficacy of anxiolytic analgesic hypnotic and anticonvulsant-like activity and is currently in phase III clinical trials for the treatment of generalized anxiety disorder.
